ORIGINAL COMPANY-CONTEXT PRACTICE
Separate compound effects from laboratory plate effects
Original practice scenario: A hypothetical research team ranks compounds using assay measurements collected on many plates and days. How would you avoid selecting a batch artifact as a promising signal?
Written for independent practice using company context; this is not a verified question from a company interview.
A REASONED APPROACH
Model answer.
Preserve experimental design and measurement context before ranking compounds. Plate position, assay day and control behavior may explain apparent differences unrelated to the compound.
Work through it
- Retain compound, replicate, plate, well and run identifiers with control measurements and quality flags, separating technical replicates from independent biological evidence.
- Use controls to examine batch shifts and justified normalization, then compare effects with uncertainty across independent runs rather than pooling all wells as equivalent samples.
- Confirm selected candidates on separately collected evidence and report failed quality checks or missing replicates explicitly.
Tradeoffs to discuss
- More replication improves reliability but reduces the number of compounds screened under a fixed budget; aggressive normalization can remove genuine effects.
Common pitfalls
- Do not select and validate on the same plates while claiming an independent confirmation.
- This computational ranking is a research aid and does not establish clinical efficacy or safety.